Literature DB >> 9151811

Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades.

M H Bachmann1, C Mathiason-Dubard, G H Learn, A G Rodrigo, D L Sodora, P Mazzetti, E A Hoover, J I Mullins.   

Abstract

For the rapid genetic analysis of feline immunodeficiency virus (FIV), we developed a heteroduplex mobility assay (HMA) that utilizes a PCR-amplified fragment of the FIV envelope gene spanning the third and fourth variable regions of the envelope surface protein coding sequence. Viral sequences were successfully amplified from blood specimens from 98 naturally infected cats from Australia, Canada, Germany, Italy, South Africa, and the United States. Eighty were clearly assignable to the A or B envelope sequence subtypes. Three belonged to subtype C, one was dually infected with viruses harboring the A and B env subtypes, and several were categorized as outliers to any of the established subtypes or as probable intersubtype recombinants. Some geographic clustering was evident, with subtypes A and B found in greater frequency in the western and eastern regions of the United States, respectively. Subtypes A, B, and C were found on more than one continent, and countries with more than two samples analyzed contained at least two subtypes. The broadest representation of subtypes was found in Munich, Germany, where three subtypes and one virus that was not classifiable by HMA were found. Thirteen samples were selected for DNA sequence determination over the same region of env used for HMA. Analysis of all available FIV env sequences from this and previous studies revealed the existence of recombinant viruses generated from subtype A/B, B/D, and A/C envelope gene sequences. Subtype A env sequences were less diverse than subtype B sequences, although both groups had well-supported clusters. Furthermore, the mutational pattern giving rise to diversification in the two subtypes differed, with the subtype A viruses showing half as many synonymous site mutations compared to subtype B yet showing similar levels of nonsynonymous site changes. These results are consistent with the hypothesis that FIV-B is an older virus group and is possibly more host adapted than FIV-A.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151811      PMCID: PMC191639     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  Sex and recombination in retroviruses.

Authors:  H M Temin
Journal:  Trends Genet       Date:  1991-03       Impact factor: 11.639

Review 2.  Viral counts count in HIV infection.

Authors:  D D Ho
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

3.  Common mechanism of infection by lentiviruses.

Authors:  B J Willett; M J Hosie; J C Neil; J D Turner; J A Hoxie
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

4.  Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.

Authors:  J S Yang; R V English; J W Ritchey; M G Davidson; T Wasmoen; J K Levy; D H Gebhard; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay.

Authors:  E L Delwart; B Herring; A G Rodrigo; J I Mullins
Journal:  PCR Methods Appl       Date:  1995-04

6.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences.

Authors:  A C Siepel; A L Halpern; C Macken; B T Korber
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

7.  Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes.

Authors:  W C Brown; L Bissey; K S Logan; N C Pedersen; J H Elder; E W Collisson
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Recombination in AIDS viruses.

Authors:  D L Robertson; B H Hahn; P M Sharp
Journal:  J Mol Evol       Date:  1995-03       Impact factor: 2.395

9.  Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; L A Obert; E A Hoover
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes.

Authors:  S Kakinuma; K Motokawa; T Hohdatsu; J K Yamamoto; H Koyama; H Hashimoto
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  51 in total

1.  Position and degree of mismatches and the mobility of DNA heteroduplexes.

Authors:  D A Upchurch; R Shankarappa; J I Mullins
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

2.  Phylogenetic analyses of Texas isolates indicate an evolving subtype of the clade B feline immunodeficiency viruses.

Authors:  Eric A Weaver; Ellen W Collisson; Margaret Slater; Guan Zhu
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars.

Authors:  Roman Biek; Allen G Rodrigo; David Holley; Alexei Drummond; Charles R Anderson; Howard A Ross; Mary Poss
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis.

Authors:  Madhu Ravi; Gary A Wobeser; Susan M Taylor; Marion L Jackson
Journal:  Can Vet J       Date:  2010-03       Impact factor: 1.008

5.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

6.  Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats.

Authors:  Chengming Wang; Calvin M Johnson; Sudhir K Ahluwalia; Erfan Chowdhury; Yihang Li; Dongya Gao; Anil Poudel; K Shamsur Rahman; Bernhard Kaltenboeck
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

7.  Recombination in feline immunodeficiency virus genomes from naturally infected cougars.

Authors:  Trevor C Bruen; Mary Poss
Journal:  Virology       Date:  2007-04-18       Impact factor: 3.616

Review 8.  Advances in FIV vaccine technology.

Authors:  Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2008-01-20       Impact factor: 2.046

9.  Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.

Authors:  James K Coleman; Ruiyu Pu; Marcus M Martin; Ezra N Noon-Song; Raphael Zwijnenberg; Janet K Yamamoto
Journal:  Vaccine       Date:  2013-06-22       Impact factor: 3.641

10.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.

Authors:  Mauro Pistello; Donatella Matteucci; Francesca Bonci; Patrizia Isola; Paola Mazzetti; Lucia Zaccaro; Antonio Merico; Daniela Del Mauro; Norman Flynn; Mauro Bendinelli
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.